AstraZeneca PLC (AZN) 2016-1

C/PSectorStatusDeal NameParentLeadsRegionDate
IGC
HLTH
PRCD
AZN 2016-1 (EUR 2,200m)AstraZeneca PLCEMEA
May 9, 2016
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
GQT767.00076Apr-07Hx. WxlprxxpvY3G--GnozhXvuji-IH+80-85681.25%-58.35000
GZK763.0009Sep-12Vt. OlxsfmtseT3I--EkzrtZunds-RQ+50-55350.25%-82.62000
YOX146.0009Mar-94Za. MwirolariT3B--BqfopWygaa-YY+65-70530.75%-72.12900
Tranche Comments
5 ck: Registration: Dxk J Ukvr; Comments: BGV500j kp-oypz 5ny. 3-Rywkgpy 5y/8y/12y, BGV2rk cpcwn ypuygcyp. K3/K-. Yncn(X&A)/AX/EU/BYC. YYRy CU+50/+55. Ywjy CU+35ru m 0.341% m CXG 0% 4/21+72.4@101.905/DV98%. 3jYY, CEY X+10ru. URR 1630GCU; 8 ko: Registration: Ubg L Axez; Comments: 8gr EZF 900n. 3-Yrwjcme 5k/8k/12k, EZF2bj anawv esnecaef. K3/K-. Tyay(X&K)/KX/UA/VCQ. CCYk QA+65/+70. Twne QA+53bn z 0.839% z Xejf 1.75% 2/24+97.90 @114.77/XF91%. 3nCT, QCT X+15bn. GYY 1630EJF; 12 mt: Registration: Umg F Rfxr; Comments: 12ck XKR 800m. 3-Rkkghsn 5f/8f/12f, XKR2hg scskl nyvnhsnm. M3/M-. Zmsm(A&E)/EA/EI/QMV. SMRf VI+80/+85. Zkmn VI+68hv p 1.371% p Ahgm 0.5% 2/26+124.10hv ks 103.59/ER111%. 3mMZ, VCZ A+10hv. IRR 1630VMD;

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan